Budde, Lihua E
Sehn, Laurie H
Matasar, Matthew
Schuster, Stephen J
Assouline, Sarit
Giri, Pratyush
Kuruvilla, John
Canales, Miguel
Dietrich, Sascha
Fay, Keith
Ku, Matthew
Nastoupil, Loretta
Cheah, Chan Yoon
Wei, Michael C
Yin, Shen
Li, Chi-Chung
Huang, Huang
Kwan, Antonia
Penuel, Elicia
Bartlett, Nancy L
Funding for this research was provided by:
Genentech
F. Hoffmann-La Roche
This article is maintained by: Elsevier
Article Title: Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
Journal Title: The Lancet Oncology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1470-2045(22)00335-7
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1470-2045(22)00385-0
Content Type: article
Copyright: © 2022 Elsevier Ltd. All rights reserved.